What is Amphastar Pharmaceuticals's change in other assets?

Amphastar Pharmaceuticals (AMPH) reported change in other assets of $2.33M in Q1 2026.

How has Amphastar Pharmaceuticals's change in other assets changed year-over-year?

Amphastar Pharmaceuticals's change in other assets increased by 174.0% year-over-year, from $849K to $2.33M.

What is the long-term trend for Amphastar Pharmaceuticals's change in other assets?

Over 2 years (2022 to 2024), Amphastar Pharmaceuticals's change in other assets has grown at a 140.5% compound annual growth rate (CAGR), from $1.85M to $10.73M.

What does change in other assets mean?

Change in miscellaneous assets affecting operating cash flow.

Amphastar Pharmaceuticals AMPH Change in Other Assets

Change in Other Assets at other companies

PfizerPFE

-$322.25M+61.9%

Halozyme TherapeuticsHALO

$9.11M+82.3%

Opko HealthOPK

-$6.97M-155%

AptarGroupATR

$12.39M-1.8%

ARS Pharmaceuticals, Inc.SPRY

$524K-89.1%

Amneal Pharmaceuticals, Inc.AMRX

$13.4M+2,512%

Other financials

Income statement

See full

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

See full

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

See full

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

See full

Market cap$927.72M-19.9%

Enterprise value$1.44B-11.3%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

See full

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

See full

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amphastar Pharmaceuticals's change in other assets?: Amphastar Pharmaceuticals (AMPH) reported change in other assets of $2.33M in Q1 2026.
How has Amphastar Pharmaceuticals's change in other assets changed year-over-year?: Amphastar Pharmaceuticals's change in other assets increased by 174.0% year-over-year, from $849K to $2.33M.
What is the long-term trend for Amphastar Pharmaceuticals's change in other assets?: Over 2 years (2022 to 2024), Amphastar Pharmaceuticals's change in other assets has grown at a 140.5% compound annual growth rate (CAGR), from $1.85M to $10.73M.
What does change in other assets mean?: Change in miscellaneous assets affecting operating cash flow.